Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Grant/Award of 41,800 INO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 41,800 | n/a |
| May 15, 2026 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 31,250 | n/a |
| Jan 7, 2026 | BICYCLE THERAPEUTICS PLC (BCYC) | Grant/Award | 3,032 | n/a |
| Nov 10, 2025 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 50,000 | n/a |
| Sep 10, 2025 | BICYCLE THERAPEUTICS PLC (BCYC) | Grant/Award | 12,500 | n/a |
| May 21, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,167 | n/a |
| Jun 26, 2024 | Kronos Bio, Inc. (KRON) | Grant/Award | 34,000 | n/a |
| May 22, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 2,917 | n/a |
| May 16, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,166 | n/a |
| May 13, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 1,000 | n/a |